Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Clin Genitourin Cancer. 2012 Sep 25;10(4):225–231. doi: 10.1016/j.clgc.2012.08.002

Figure 1.

Figure 1

Baseline Thyroid-Stimulating Hormone (TSH) and Peak TSH. Average Baseline and Peak TSH for All Patients Treated With Sorafenib as Compared to Sunitinib